LONDON, April 1, 2014 /PRNewswire/ --
The US markets saw a positive sentiment on Monday, March 31, 2014, with the NASDAQ Composite closing at 4,198.99, up 1.04%, the Dow Jones Industrial Average ending the session at 16,457.66, up 0.82% and the S&P 500 edging 0.79% higher to finish the trading session at 1,872.34. The gains were broad based as nine out of 10 sectors ended the session in positive. A number of stocks saw large movements, including Teva Pharmaceutical Industries Ltd (NYSE: TEVA), Capstone Turbine Corp. (NASDAQ: CPST), Cigna Corp. (NYSE: CI) and Galena Biopharma Inc. (NASDAQ: GALE). Free technical research on TEVA, CPST, CI and GALE can be downloaded upon signing up at:
http://www.investor-edge.com/629-register
Shares in Teva Pharmaceutical Industries Ltd edged 6.86% higher, finishing Monday's session at $52.84, hitting a new 52-week high of $52.94. The stock fluctuated between $49.60 and $52.94 during the session with a trading volume of 13.63 million shares as compared to a three months average volume of 6.82 million shares. Shares in Teva Pharmaceutical Industries Ltd have surged 8.10% in the previous three trading sessions, 5.91% in the last one month, and 31.84% on YTD basis. The S&P 500 Health Care Sector Index mapped a gain of 1.27% during the trading session and charted up 5.40% in the previous three months. Furthermore, the stock has a Relative Strength Index (RSI) of 56.70 and is trading above its 50-day and 200-day moving averages of $47.01 and $41.25. On the same day, Teva Pharmaceutical Industries Ltd announced that the U.S. Supreme Court has granted its COPAXONE certiorari petition and will hear its appeal of a decision from the United States Court of Appeals for the Federal Circuit that invalidated the claim of U.S. Patent 5,800,808. Sign up today to read free research on TEVA at:
http://www.investor-edge.com/629-TEVA-01Apr2014.pdf
On Monday, shares in Capstone Turbine Corp. ended the session at $2.13, up 5.97%. A total of 6.07 million shares were traded, as compared to a three months average volume of 8.13 million shares. During the session, the stock traded between $2.01 and $2.15. Capstone Turbine Corp.'s shares have rallied 18.99% in the last one month, 65.12% in the previous three months and 65.12% on YTD basis. The S&P 500 Industrials Sector Index mapped a gain of 1.03% during the trading session and charted up 0.79% in the last one month. Further, the stock has an RSI of 48.10 and is trading above its 50-day and 200-day moving averages of $1.84 and $1.40, respectively. Sign up today to read free research on CPST at:
http://www.investor-edge.com/629-CPST-01Apr2014.pdf
Cigna Corp.'s stock finished Monday's session at $83.73, up 5.44%. A total of 5.91 million shares were traded, which is above the three months average volume of 2.09 million shares. The stock vacillated between $80.13 and $84.28 during the session. Cigna Corp.'s shares have advanced 4.66% in the previous three trading sessions and 5.20% in the last one month. The company's shares traded at a PE ratio of 12.36 and have fallen by 4.29% on YTD basis. The S&P 500 Health Care Sector Index mapped a gain of 1.27% during the trading session, while the same has fallen by 1.37% in the last one month. Additionally, the stock has an RSI of 48.77 and is trading above its 50-day and 200-day moving averages of $81.15 and $80.08, respectively. Sign up today to read free research on CI at:
http://www.investor-edge.com/629-CI-01Apr2014.pdf
Shares in Galena Biopharma Inc. closed Monday's session at an intra-day high of $2.50, which is 12.61% higher than the previous day's closing price of $2.22. A total of 6.15 million shares were traded as compared to a three months average volume of 9.33 million shares. The stock oscillated between $2.18 and $2.50 during the trading session. Shares in Galena Biopharma Inc. have gained 4.60% in the previous three trading sessions, while the same has declined 36.71% in the last one month and 49.60% on YTD basis. The S&P 500 Health Care Sector Index mapped a gain of 1.27% during the trading session and 0.74% in the last three trading sessions. Moreover, the stock has an RSI of 27.15 and is trading below its 50-day and 200-day moving averages of $4.15 and $3.12, respectively. Sign up today to read free research on GALE at:
http://www.investor-edge.com/629-GALE-01Apr2014.pdf
===============
EDITOR'S NOTES:
===============
1. This is not company news. We are an independent source and our views do not reflect the companies mentioned.
2. Information in this release is fact checked and produced on a best efforts basis and reviewed by Nidhi Vatsal, a CFA charterholder. However, we are only human and are prone to make mistakes. If you notice any errors or omissions, please notify us below.
3. This information is submitted as a net-positive to companies mentioned, to increase awareness for mentioned companies to our subscriber base and the investing public.
4. If you wish to have your company covered in more detail by our team, or wish to learn more about our services, please contact us at pubco [at] http://www.investor-edge.com.
5. For any urgent concerns or inquiries, please contact us at compliance [at] http://www.investor-edge.com.
6. Are you a public company? Would you like to see similar coverage on your company? Send us a full investors' package to research [at] http://www.investor-edge.com for consideration.
COMPLIANCE PROCEDURE
Content is researched, written and reviewed on a best-effort basis. This document, article or report is prepared and authored by Investor-edge. An outsourced research services provider represented by Nidhi Vatsal, CFA, has only reviewed the information provided by Investor-edge in this article or report according to the Procedures outlined by Investor-edge. Investor-edge is not entitled to veto or interfere in the application of such procedures by the outsourced provider to the articles, documents or reports, as the case may be.
NOT FINANCIAL ADVICE
Investor-edge makes no warranty, expressed or implied, as to the accuracy or completeness or fitness for a purpose (investment or otherwise), of the information provided in this document. This information is not to be construed as personal financial advice. Readers are encouraged to consult their personal financial advisor before making any decisions to buy, sell or hold any securities mentioned herein.
NO WARRANTY OR LIABILITY ASSUMED
Investor-edge is not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted by Investor-edge whatsoever for any direct, indirect or consequential loss arising from the use of this document. Investor-edge expressly disclaims any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Investor-edge does not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.
CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.
http://www.investor-edge.com/
SOURCE Investor-Edge
